Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mayne Pharma Group ( (AU:MYX) ) has shared an announcement.
Mayne Pharma Group Limited has initiated proceedings with the Takeovers Panel regarding its affairs, specifically concerning the Scheme Implementation Deed with Cosette Pharmaceuticals, Inc. The Panel has issued interim orders to amend the End Date in the Deed to 24 November 2025, preventing Cosette from terminating the agreement without prior consent. This action aims to maintain the status quo while the Panel considers the application, impacting the ongoing merger process between Mayne and Cosette.
The most recent analyst rating on (AU:MYX) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 446,792
Technical Sentiment Signal: Sell
Current Market Cap: A$381.9M
For a thorough assessment of MYX stock, go to TipRanks’ Stock Analysis page.